Cancer · heart transplant recipients
Monoclonal antibody showed no clear difference in cancer Number of participants diagnosed with cancer compared with polyclonal antibody (low certainty).
1 finding from 1 review
Intervention not reported
Cytomegalovirus infection Number of patients diagnosed with CMV infection · heart transplant recipients
The intervention showed no clear difference in cytomegalovirus infection Number of patients diagnosed with CMV… (low certainty).
1 finding from 1 review
Intervention not reported
Post‐transplantation lymphoproliferative disorder Number of participants diagnosed with PTLD · heart transplant recipients
The intervention showed no clear difference in post‐transplantation lymphoproliferative disorder Number of… (low certainty).
1 finding from 1 review
Intervention not reported
Cancer Number of participants diagnosed with cancer · heart transplant recipients
The intervention showed no clear difference in cancer Number of participants diagnosed with cancer (low certainty).
1 finding from 1 review
Mortality Mortality at latest · heart transplant recipients
Interleukin‐2 RA showed no clear difference in mortality Mortality at latest compared with no induction (low certainty).
1 finding from 1 review
Acute rejection Acute rejection grade 3A or more verified by biopsy · heart transplant recipients
Interleukin‐2 RA showed no clear difference in acute rejection Acute rejection grade 3A or more verified by biopsy compared with no induction (low certainty).
1 finding from 1 review
Infection Number of participants diagnosed with infection · heart transplant recipients
Interleukin‐2 RA showed no clear difference in infection Number of participants diagnosed with infection compared with no induction (low certainty).
1 finding from 1 review
All‐cause death: not measured · patients with restenosis after percutaneous coronary intervention in coronary heart disease
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Restenosis Coronary angiography · patients with restenosis after percutaneous coronary intervention in coronary heart disease
Xiongshao capsule (XSC) plus conventional western medicine (CWM) leads to lower restenosis Coronary angiography compared with conventional western medicine (CWM) plus placebo (high certainty).
1 finding from 1 review
Recurrence angina pectoris with 1 month · patients with restenosis after percutaneous coronary intervention in coronary heart disease
Xiongshao capsule (XSC) plus conventional western medicine (CWM) leads to lower recurrence angina pectoris with 1 month compared with conventional western medicine (CWM) plus placebo (high certainty).
3 findings from 1 review
RR 0.31 [0.1, 0.92]
1 study · 314 participants
High
RR 0.37 [0.19, 0.71]
1 study · 314 participants
High
RR 0.26 [0.18, 0.38]
2 studies · 432 participants
High
Health‐related quality of life: not measured · patients with restenosis after percutaneous coronary intervention in coronary heart disease
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Cardiac mortality · patients with restenosis after percutaneous coronary intervention in coronary heart disease
1 finding from 1 review
Serious adverse events · patients with restenosis after percutaneous coronary intervention in coronary heart disease
Xiongshao capsule (XSC) plus conventional western medicine (CWM) leads to lower serious adverse events compared with conventional western medicine (CWM) (high certainty).
1 finding from 1 review
Restenosis Coronary angiography · patients with restenosis after percutaneous coronary intervention in coronary heart disease
Xiongshao capsule (XSC) plus conventional western medicine (CWM) leads to lower restenosis Coronary angiography compared with conventional western medicine (CWM) (high certainty).
1 finding from 1 review
Recurrence angina pectoris Treadmill exercise test · patients with restenosis after percutaneous coronary intervention in coronary heart disease
Xiongshao capsule (XSC) plus conventional western medicine (CWM) probably leads to lower recurrence angina pectoris Treadmill exercise test compared with conventional western medicine (CWM) (moderate certainty).
1 finding from 1 review
Health‐related quality of life: not measured · patients with restenosis after percutaneous coronary intervention in coronary heart disease
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
All‐cause death: not measured · patients with restenosis after percutaneous coronary intervention in coronary heart disease
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Cardiac mortality · patients with restenosis after percutaneous coronary intervention in coronary heart disease
1 finding from 1 review
Serious adverse events · patients with restenosis after percutaneous coronary intervention in coronary heart disease
Xiongshao capsule (XSC) plus conventional western medicine (CWM) leads to lower serious adverse events compared with conventional western medicine (CWM) plus placebo (high certainty).
1 finding from 1 review
Cardio‐respiratory fitness: 12 months Sub maximal assessment of cardio‐respiratory fitness · patients with promoting physical activity
1 finding from 1 review